RAMSELPHARMA
ActiveSummary
RAMSELPHARMA has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €637,252 and a net result of €124,952. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 80% of 12,713 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Articles of association
Who represents it, and how
- Who signsWho may bind the company towards others, for example by signing a contract.
- Each director alone
- Board ruleHow the board is made up, meets and takes decisions.
- “Één of meer, natuurlijke personen of rechtspersonen,al dan niet aandeelhouder” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- First Friday of June at 20:00